Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Teva Pharm to pay Oklahoma $85 million to settle opioid claims

Teva Pharmaceutical agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that the world’s largest generic manufacturer and other drugmakers helped fuel the U.S. opioid epidemic.

Read More »

Oklahoma takes on drugmakers J&J, Teva in landmark opioid trial

Oklahoma Attorney General Mike Hunter’s $17 billion lawsuit is the first to go to trial of more than 2,000 actions by state and local governments accusing opioid manufacturers of contributing to an epidemic linked to a record 47,600 overdose deaths in 2017, according to the U.S. Centers for Disease Control and Prevention.

Read More »

Five U.S. states sue Purdue Pharma over marketing, selling of opioids

Five U.S. states filed lawsuits accusing Purdue Pharma LP of illegally marketing and selling opioids, including OxyContin.

Read More »

Opioids crisis has spread beyond United States: OECD

Opioid use has reached crisis proportions not only in the United States but also in Canada and some European countries, as prescription opioid painkillers have become much more common, the OECD club of wealthy nations said.

Read More »

Founder, execs of drug company guilty in conspiracy that fed opioid crisis

The founder of Insys Therapeutics Inc. became the highest-ranking pharmaceutical executive to be convicted in a case tied to the U.S. opioid crisis, when he and four colleagues were found guilty of participating in a scheme to bribe doctors to prescribe an addictive painkiller.

Read More »

McKesson to pay $37 million to resolve West Virginia opioid lawsuit

Drug distributor McKesson Corp. agreed to pay $37 million to resolve a lawsuit by the state of West Virginia seeking to hold the company responsible for contributing to the opioid epidemic, the state’s attorney general said.

Read More »

Trump Holding Big Pharma Accountable In Opioid Fight

U.S. President Donald Trump touted progress in the fight against opioid abuse and promised to hold drugmakers accountable for their part in the crisis, a day after his administration brought its first related criminal charges against a major drug distributor and company executives.

Read More »

After drug distributor charged, Trump sets speech on opioid fight

President Donald Trump is expected to tout his fight against opioid abuse in remarks in Atlanta a day after his administration brought its first related criminal charges against a major drug distributor and company executives.

Read More »

Oklahoma drops several claims in opioid case against J&J, Teva

Oklahoma’s attorney general dropped all but a single claim against Johnson & Johnson and Teva Pharmaceutical Industries Ltd. in a closely watched lawsuit alleging the drugmakers helped fuel the U.S. opioid epidemic.

Read More »

China expands curbs on fentanyl, blames U.S. for its abuse

China will expand the range of fentanyl-related substances the country defines as controlled narcotics, a Chinese security official said, blaming U.S. culture for abuse of the drug.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom